Skip to main content

Aeglea BioTherapeutics, Inc. - Common Stock (NQ: AGLE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 27, 2023 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
May 02, 2019
Form DEF 14A
Source: SEC/Edgar
April 21, 2019
Form 8-K
Source: SEC/Edgar
April 07, 2019
Form CT ORDER
Source: SEC/Edgar
March 18, 2019
Form 8-K
Source: SEC/Edgar
March 07, 2019
Form S-8
Source: SEC/Edgar
March 06, 2019
Form 8-K
Source: SEC/Edgar
March 06, 2019
Form SC 13G/A
Source: SEC/Edgar
February 13, 2019
Form SC 13G/A
Source: SEC/Edgar
February 13, 2019
Form 424B5
Source: SEC/Edgar
February 12, 2019
Form EFFECT
Source: SEC/Edgar
February 12, 2019
Form SC 13G/A
Source: SEC/Edgar
February 12, 2019
Form SC 13G/A
Source: SEC/Edgar
February 12, 2019
Form S-3/A
Source: SEC/Edgar
February 10, 2019
Form SC 13G
Source: SEC/Edgar
February 07, 2019
Form 424B5
Source: SEC/Edgar
February 06, 2019
Form 8-K
Source: SEC/Edgar
February 06, 2019
Form 424B5
Source: SEC/Edgar
February 04, 2019
Form SC 13G/A
Source: SEC/Edgar
February 04, 2019
Form SC 13G/A
Source: SEC/Edgar
January 30, 2019
Form SC 13G/A
Source: SEC/Edgar
January 30, 2019
Form 8-K
Source: SEC/Edgar
December 20, 2018
Form S-3
Source: SEC/Edgar
December 20, 2018
Form 8-K
Source: SEC/Edgar
December 10, 2018
Form 8-K
Source: SEC/Edgar
December 10, 2018
Form 8-K
Source: SEC/Edgar
November 28, 2018
Form 8-K
Source: SEC/Edgar
November 07, 2018
Form 8-K
Source: SEC/Edgar
October 21, 2018
Form 8-K
Source: SEC/Edgar
October 16, 2018
Form SC 13G
Source: SEC/Edgar
October 10, 2018
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.